Single-subject Proteomic Signatures in Alzheimer’s Disease Reflect Clinical Phenotypes and Distinguish Asymptomatic from Symptomatic Cases

These results demonstrate that single-subject omics profiling can resolve individual molecular signatures aligned with clinical and neuropathological variation in AD. By linking molecular heterogeneity with disease phenotypes, INDIGO provides a scalable framework for precision modeling and novel therapeutic target discovery.